• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外联合化疗。IV. 人结肠癌细胞对顺二氯二氨铂联合用药的反应

Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations using cis-diamminedichloroplatinum.

作者信息

Bergerat J P, Green C, Drewinko B

出版信息

Cancer Biochem Biophys. 1979;3(4):173-80.

PMID:575983
Abstract

Combination effects of cis-dichlorodiammine platinum (II) (DDP) paired with 12 other antineoplastic agents were investigated on a human carcinoembryonic antigen producing colon carcinoma cell line in vitro. DDP was effective in increasing the killing efficiency of many different drugs. Supraadditive effects were noted with hydroxyurea, bleomycin, cis-acid, BCNU, adriamycin and mitomycin C, and a marked synergistic effect was noted with ara-C. DDP displayed simple additive effects wit 5-fluorouracil (5-FU), Ftorafur and methotrexate, and subadditive effects in simultaneous combination with vincristine. In view of its powerful cytotoxic effects on this particular cell line and of the supraadditive effects of its combinations with nitrosoureas and mitomycin C, DDP appears as a potentially useful antineoplastic agent for combination therapeutic regimens for human colon carcinoma.

摘要

在体外对一株产生人癌胚抗原的结肠癌细胞系研究了顺二氯二氨铂(II)(DDP)与其他12种抗肿瘤药物联用的效果。DDP能有效提高许多不同药物的杀伤效率。羟基脲、博来霉素、顺式酸、卡氮芥、阿霉素和丝裂霉素C呈现超相加效应,阿糖胞苷呈现显著的协同效应。DDP与5-氟尿嘧啶(5-FU)、呋氟尿嘧啶和甲氨蝶呤联用表现为简单相加效应,与长春新碱同时联用表现为次相加效应。鉴于DDP对该特定细胞系有强大的细胞毒性作用,以及它与亚硝基脲类和丝裂霉素C联用的超相加效应,DDP似乎是一种对人结肠癌联合治疗方案可能有用的抗肿瘤药物。

相似文献

1
Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations using cis-diamminedichloroplatinum.体外联合化疗。IV. 人结肠癌细胞对顺二氯二氨铂联合用药的反应
Cancer Biochem Biophys. 1979;3(4):173-80.
2
Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.1-β-D-阿拉伯呋喃糖基胞嘧啶诱导顺二氨二氯铂(II)细胞毒性增强的动力学及机制
Cancer Res. 1986 Mar;46(3):1105-9.
3
Combination chemotherapy in vitro with adriamycin. Observations of additive, antagonistic, and synergistic effects when used in two-drug combinations on cultured human lymphoma cells.阿霉素体外联合化疗。观察其与其他药物联合用于培养的人淋巴瘤细胞时的相加、拮抗和协同作用。
Cancer Biochem Biophys. 1976 May;1(4):187-95.
4
1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking.1-β-D-阿拉伯呋喃糖基胞嘧啶与羟基脲联合顺二氯二氨合铂(II)产生细胞毒性协同作用及对铂诱导的DNA链间交联的修饰
Cancer Res. 1989 Mar 15;49(6):1383-9.
5
Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.沙巴柔比星(MEN 10755)与顺铂(DDP)联合治疗对人肺肿瘤异种移植瘤的抗肿瘤作用
Cancer Chemother Pharmacol. 2008 Sep;62(4):621-9. doi: 10.1007/s00280-007-0645-y. Epub 2007 Nov 24.
6
Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.烷化剂:人类细胞系中交叉耐药模式的体外研究
Cancer Res. 1986 Sep;46(9):4379-83.
7
Combination chemotherapy in vitro with cis-dichlorodiammineplatinum(II).顺二氯二氨合铂(II)的体外联合化疗
Cancer Treat Rep. 1976 Nov;60(11):1619-25.
8
Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).顺二氯二氨铂(II)使人类膀胱癌细胞对Fas介导的细胞毒性敏感化。
J Urol. 1998 Aug;160(2):561-70.
9
In vitro pharmacodynamics of 1-beta-D-arabinofuranosylcytosine: synergy of antitumor activity with cis-diamminedichloroplatinum(II).1-β-D-阿拉伯呋喃糖基胞嘧啶的体外药效学:与顺二氨二氯铂(II)的抗肿瘤活性协同作用。
Cancer Res. 1988 Jan 1;48(1):117-21.
10
Effects of cis-dichlorodiammineplatinum(II) on human colon carcinoma cells in vitro.顺二氯二氨合铂(II)对人结肠癌细胞的体外作用。
Cancer Res. 1979 Apr;39(4):1334-8.

引用本文的文献

1
Intracavitary chemotherapy for malignant disease confined to body cavities.腔内化疗用于局限于体腔的恶性疾病。
West J Med. 1985 Mar;142(3):364-8.